Stay updated with breaking news from Sponsored Level. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Approval heralds the second rare cholestatic liver disease indication for Bylvay in the U.S. after progressive familial intrahepatic cholestasis related pruritus in 2021 Immediate U.S. commercial... | June 13, 2023
Seven abstracts to be presented demonstrating treatment effects of Bylvay® in two cholestatic liver diseases, progressive familial intrahepatic cholestasis and Alagille syndrome Data to be... | June 12, 2023
01.06.2023 - REGULATED INFORMATION Ipsen initiates a share buy-back programto cover its free employee share-allocation plan Paris (France), 1 June 2023 - Ipsen (Euronext: IPN; ADR: IPSEY) has appointed an investment-services provider to purchase an aggregate ...
REGULATED INFORMATION Description of the regulatory framework of the share repurchase programproposed by the Board of Directors to be approved at theCombined Shareholders’ Meeting... | May 31, 2023
REGULATED INFORMATION COMBINED SHAREHOLDERS’ MEETING OF IPSEN S.A.HELD ON 31 MAY 2023 ALL THE RESOLUTIONS SUBMITTED TO THE SHAREHOLDERS’ VOTE HAVE BEEN APPROVED Paris , 31 May... | May 31, 2023